IVC INDUSTRIES INC
NT 10-K, 1997-10-30
PHARMACEUTICAL PREPARATIONS
Previous: PARADIGM MEDICAL INDUSTRIES INC, 10QSB/A, 1997-10-30
Next: IVC INDUSTRIES INC, 10-K, 1997-10-30




                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

  
                                   FORM 12b-25
  
  
                           NOTIFICATION OF LATE FILING

(Check One):
  
 |X| Form 10-K or Form 10-KSB |_| Form 20-F |_| Form 11-K |_| Form 10-Q 
 |_| Form N-SAR

     For Period Ended: July 31, 1997
     [ ] Transition Report on Form 10-K
     [ ] Transition Report on Form 20-F
     [ ] Transition Report on Form 11-K
     [ ] Transition Report on Form 10-Q
     [ ] Transition Report on Form N-SAR
     For the Transition Period Ended: __________________________________

- - --------------------------------------------------------------------------------
  Read Instruction (on back page) Before Preparing Form. Please Print or Type.

    Nothing in this form shall be construed to imply that the Commission has
                   verified any information contained herein.
- - --------------------------------------------------------------------------------
If the notification relates to a portion of the filing checked above, identify
the Item(s) to which the notification relates:

- - --------------------------------------------------------------------------------

PART I -- REGISTRANT INFORMATION

IVC Industries, Inc.
- - --------------------------------------------------------------------------------
Full Name of Registrant

- - --------------------------------------------------------------------------------
Former Name if Applicable

500 Halls Mill Road
- - --------------------------------------------------------------------------------
Address of Principal Executive Office (Street and Number)

Freehold, New Jersey  07728
- - --------------------------------------------------------------------------------
City, State and Zip Code

PART II -- RULES 12b-25(b) AND (c)

If the subject report could not be filed without unreasonable effort or expense
and the registrant seeks relief pursuant to Rule 12b-25(b), the following should
be completed. (Check box if appropriate)

  |X|  | (a) The reasons described in reasonable detail in Part III of this form
       |     could not be eliminated without unreasonable effort or expense;
       |
  |X|  | (b) The subject annual report, semi-annual report, transition report on
       |     Form 10-K, Form 10-KSB, Form 20-F, Form 11-K or Form N-SAR, 
       |     or portion thereof, will be filed on or before the fifteenth 
       |     calendar day following the prescribed due date; or the calendar day
       |     following the prescribed due date; and subject quarterly report of 
       |     transition report on Form 10-Q, or portion thereof will be filed on
       |     or before the fifth calendar day following the prescribed due date;
       |     and
       |
       | (c) The accountant's statement or other exhibit required by Rule 
       |     12b-25(c) has been attached if applicable.

PART III -- NARRATIVE

State below in reasonable detail the reasons why Forms 10-K, 10-KSB, 20-F, 11-K,
10-Q, N-SAR, or the transition report or portion thereof, could not be filed
within the prescribed time period.

     In June 1997, Registrant acquired the Vitamin Specialties(R) brand and
     related distribution operations of Health Rite, Inc., including a chain of
     15 retail stores and a mail order catalogue operation. Accordingly, more
     time was needed to integrate financial data and other information, some of
     which was contained in software that was not compatible with software used
     by the Company.                        
                        (Attach Extra Sheets if Needed)
<PAGE>

PART IV--OTHER INFORMATION

(1) Name and telephone number of person to contact in regard to this
    notification

            I. Alan Hirschfeld                           (732) 308-3000
- - --------------------------------------------------------------------------------
                 (Name)                                (Telephone Number)

(2) Have all other periodic reports required under Section 13 or 15(d) of the
    Securities Exchange Act of 1934 or Section 30 of the Investment Company Act
    of 1940 during the preceding 12 months or for such shorter period that the
    registrant was required to file such report(s) been filed? If answer is no,
    identify report(s).                                           |X| Yes |_| No

(3) Is it anticipated that any significant change in results of operations from
    the corresponding period for the last fiscal year will be reflected by the
    earnings statements to be included in the subject report or portion thereof?
                                                                  |_| Yes |X| No
    
    If so, attach an explanation of the anticipated change, both narratively and
    quantitatively, and, if appropriate, state the reasons why a reasonable
    estimate of the results cannot be made.

================================================================================

                              IVC Industries, Inc.
              ----------------------------------------------------
                  (Name of Registrant as Specified in Charter)

has caused this notification to be signed on its behalf by the undersigned
hereunto duly authorized.


Date October 29, 1997              By  /s/ I. Alan Hirschfeld
     ----------------                 ------------------------------------------
                                      I. Alan Hirschfeld
                                      Executive Vice President
                                      and acting Chief Financial Officer

INSTRUCTION: The form may be signed by an executive officer of the registrant or
by any other duly authorized representative. The name and title of the person
signing the form shall be typed or printed beneath the signature. If the
statement is signed on behalf of the registrant by an authorized representative
(other than an executive officer), evidence of the representative's authority to
sign on behalf of the registrant shall be filed with the form.

- - ----------------------------------- ATTENTION ----------------------------------
   Intentional misstatements or omissions of fact constitute Federal Criminal
                        Violations (See 18 U.S.C. 1001).
- - --------------------------------------------------------------------------------

                              GENERAL INSTRUCTIONS

1.  This form is required by Rule 12b-25 (17 CFR 240.12b-25) of the General
    Rules and Regulations under the Securities Exchange Act of 1934.

2.  One signed original and four conformed copies of this form and amendments
    thereto must be completed and filed with the Securities and Exchange
    Commission, Washington, D.C. 20549, in accordance with Rule 0-3 of the
    General Rules and Regulations under the Act. The information contained in or
    filed with the form will be made a matter of public record in the Commission
    files.

3.  A manually signed copy of the form and amendments thereto shall be filed
    with each national securities exchange on which any class of securities of
    the registrant is registered.

4.  Amendments to the notifications must also be filed on form 12b-25 but need
    not restate information that has been correctly furnished. The form shall be
    clearly identified as an amended notification.

5.  Electronic Filers. This form shall not be used by electronic filers unable
    to timely file a report solely due to electronic difficulties. Filers unable
    to submit a report within the time period prescribed due to difficulties in
    electronic filing should comply with either Rule 201 or Rule 202 of
    Regulation S-T (ss.232.201 or ss.232.202 of this chapter) or apply for an
    adjustment in filing date pursuant to Rule 13(b) of Regulation S-T
    (ss.232.13(b) of this chapter).



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission